突発性難聴677例の重症度別治療成績

書誌事項

タイトル別名
  • A Clinical Study of 677 Cases of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
  • 臨床 突発性難聴677例の重症度別治療成績
  • リンショウ トッパツセイ ナンチョウ 677レイ ノ ジュウショウド ベツ チリョウ セイセキ

この論文をさがす

説明

We studied 677 cases with idiopathic sudden sensorineural hearing loss (ISSNHL) treated with at least intravenous batroxobin, oral betamethasone, and hyperbaric oxygen therapy. The 677 patients received at least intravenous batroxobin from 2005 to 2008.<br> Overall “cure” was 30.7%, 44.2% for Grade 1, 34.4% for Grade 2, 32.2% for Grade 3, and 8.1% for Grade 4. Within the twelve days between onset and treatment start, “cure” was 38.2%. Hearing loss severity and the duration both significantly influenced hearing recovery.<br>

収録刊行物

被引用文献 (4)*注記

もっと見る

参考文献 (21)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ